Genetic alterations in Ki-ras and Ha-ras genes in Juvenile Nasopharyngeal Angiofibromas and head and neck cancer
Keywords:
Ras gene family, Squamous cell carcinoma of the head and neck, Juvenile nasopharyngeal angiofibroma, Gene expression; MutationsAbstract
CONETXT: Ras gene mutations have been associated to a wide range of human solid tumors. Members of the ras gene family (Ki-ras, Ha-ras and N-ras) are structurally related and code for a protein (p21) known to play an important role in the regulation of normal signal transduction and cell growth. The frequency of ras mutations is different from one type of tumor to another, suggesting that point mutations might be carcinogen-specific. OBJECTIVES: To study the occurrence of Ki-ras and Ha-ras mutations. We also studied the relative level of Ha-ras mRNA in 32 of the head and neck tumors. DESIGN: Case series. SETTING: University referral unit. PARTICIPANTS: 60 head and neck tumors and in 28 Juvenile Nasopharyngeal Angiofibromas (JNA). DIAGNOSTIC TEST: Using PCR-SSCP we examined the occurrence of Ki-ras and Ha-ras mutations. The relative level of Ha-ras mRNA was examined by Northern blot analysis. RESULTS: None of the head and neck tumors or JNA samples showed evidence of mutations within codons 12, 13, 59 and 61 of Ki-ras or Ha-ras genes. However, 17 (53%) of the tumors where gene expression could be examined exhibited increased levels of Ha-ras mRNA compared with the normal tissue derived from the same patient. CONCLUSIONS: Our results demonstrate for the first time that mutations of Ki-ras and Ha-ras genes are not associated with the development of JNA and confirm previous reports indicating that activating ras mutations are absent or rarely involved in head and neck tumors from western world patients. Furthermore, our findings suggest that overexpression of Ha-ras, rather than mutations, might be an important factor in the development and progression of head and neck tumors.
Downloads
References
Parkin DM, Laara E, Muir CS. Estimates of the worldwide frequency of 16 major cancers in 1980. Int J Cancer 1988;41:184-7.
Mirra AP, Franco EL. Incidęncia de Câncer no Município de Săo Paulo. Săo Paulo, Instituto Ludwig de Pesquisa sobre o Câncer; 1985.
Franco EL. Estimativas de incidęncia de câncer no Estado de Săo Paulo. Fundaçăo Oncocentro de Săo Paulo, Săo Paulo; 1990.
Ferouz AS, Mohr RM, Paul P. Juvenile nasopharyngeal angiofibroma and familial adenomatous polyposis: an association? Otolaryngol Head and Neck Surg 1995;113:435-9.
Finerman WB. Juvenile nasopharyngeal angiofibroma in the female. Arch Otolaryngol Head Neck Surg 1951;54:620-3.
Sternberg SS. Pathology of juvenile nasopharyngeal angiofibroma - a lesion of adolescent males. Cancer 1954;7:15-28.
Brentani MM, Butugan O, Oshima CTF, Torloni H, Paiva L. Multiple steroid receptors in nasopharyngeal angiofibromas. Laryngoscope 1989;102:641-4.
Barbacid M. Ras genes. Annu. Rev. Biochem 1987;56:779-827.
Bos JL. Ras oncogenes in human cancer: a review. Cancer Res. 1989;49:4682-9.
Yeudall WA, Torrance LK, Elsegood KA, Speight P, Scully C, Prime SS. Ras gene point mutation is a rare event in premalignant tissues and malignant cell tissues from oral mucosal lesions. Eur J Cancer Oral Oncol 1993;29B(1):63-7.
Rumsby G, Carter RL, Gusterson BA. Low incidence of ras oncogene activation in human squamous cell carcinomas. Br J Cancer 1990;61:365-8.
Sheng ZM, Barrois M, Klijanienko J, Micheau C, Richard JM, Riou G. Analysis of the c-Ha-ras-1 gene for deletion, mutation, amplification and expression in lymph node metastases of human head and neck carcinomas. Br J Cancer 1990;62:398-404.
Chang SE, Bhatia P, Johnson NW, et al Ras mutations in United Kingdom: examples of oral malignancies are infrequent. Int J Cancer 1991;48:409-12.
Yarbrough WG, Shores C, Witsel DL, Weinsler MC, Fidler ME, Gilmer TM. Ras mutations and expression in head and neck squamous cell carcinomas. Laryngoscope 1994;104(11):1337-47.
Nunez F, Dominguez O, Coto E, Suarez-Nieto C, Perez P, Lopez-Larrea C. Analysis of ras oncogene mutations in human squamous cell carcinoma of the head and neck. Surg Oncol 1992;1(6):405-11.
Saranath D, Chang SE, Bhoite LT, et al High frequency mutations in codons 12 and 61 of Ha-ras oncogene in chewing tobacco-related human oral carcinoma in India. Br J Cancer 1991;63:573-78.
Yuan B, Oechsli MN, Hendler FJ. A region within murine chromosome 7F4, syntenic to the human 11q13 amplicon, is frequently amplified in 4NQO-induced oral cavity tumors. Oncogene 1997;15:1161-70.
Field JK. Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck. Eur J Cancer Oral Oncol 1992;28B(1):67-76.
Kiaris H, Spandidos DA, Jones AS, Vaughan ED, Field JK. Mutations, expression and genomic instability of the H-ras protooncogene in squamous cell carcinomas of the head and neck. Br J Cancer 1995;72:123-8.
Giardiello FM, Hamilton SR, Krush AJ, Offerhaus JA, Booker SV, Petersen GM. Nasopharyngeal angiofibroma in patients with familial adenomatous polyposis. Gastroenterology 1993;105:1550-2.
Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
Ichikawa Y, Nishida M, Suzuki H, et al Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors. Cancer Res 1994;54:33-5.
Irish JC, Bernstein A. Oncogenes in head and neck cancer. Laryngoscope 1993;103:42-52.
Kuo MYP, Jeng JH, Chiang CP, Hahn LJ. Mutations of Ki-ras oncogene codon 12 in betel quid chewing-related human oral squamous cell carcinomas in Taiwan. Oral Pathol Med 1994;23:70-4.
Slamon DJ, De Kernion JB, Verma IM, et al Expression of cellular oncogenes in human malignancies. Science 1984;224:256-62.
Thor A, Ohuchi N, Hand PH, et al Ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues. Lab Invest 1986;55:603-15.
Archer SG, Eliopoulos A, Spandidos DA, et al Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy. Br J Cancer 1995;72:1259-266.
Iwasaka T, Yokoyama M, Hayashi Y, Sugimori H. Human papillomavirus 16 and 18 DNA can solely induce oncogenic transformation of mammalian cells in primary culture. Acta Obstet Gynecol Scand 1993;72:81-6.
Anderson JA, Irish JC, McLachlin CM, Ngan BY. H-ras oncogene mutation and human papillomavirus infection in oral carcinomas. Arch Otolaryngol Head Neck Surg 1994;120:755-60.
Azuma M, Furumoto N, Kawamata H, et al The relation of ras oncogene product p21 expression to clinicopathological status criteria and clinical outcome in squamous cell head and neck cancer. Cancer J 1987;1:375-80.
